acut
respiratori
tract
infect
arti
major
caus
morbid
mortal
worldwid
particularli
infant
young
children
may
experi
multipl
infect
per
year
year
age
cost
attribut
viral
lower
respiratori
tract
infect
outpati
inpati
set
signific
burden
healthcar
budget
arnold
et
al
virus
respons
major
acut
respiratori
tract
infect
respiratori
syncyti
viru
rsv
influenza
viru
inf
parainfluenza
virus
piv
adenoviru
human
metapneumoviru
hmpv
consid
common
pathogen
thu
accur
tool
etiolog
diagnosi
critic
maintain
reason
use
antibiot
effect
epidem
control
tradit
diagnosi
respiratori
infect
reli
isol
identif
viral
agent
cell
cultur
detect
viral
antigen
direct
immunofluoresc
assay
dfa
arnold
et
al
satisfi
adequ
clinic
need
due
sensit
recent
advanc
molecular
biolog
particularli
introduct
pcr
assay
improv
greatli
detect
individu
viral
respiratori
pathogen
louie
et
al
promot
develop
multiplex
assay
detect
simultan
multipl
pathogen
singl
test
multiplex
technolog
potenti
applic
test
other
allow
rapid
test
howev
assay
still
use
wide
clinic
laboratori
current
avail
research
use
studi
need
elucid
perform
characterist
determin
ideal
clinic
applic
caliendo
electrospray
ioniz
mass
spectrometri
coupl
pcr
technolog
simultan
multiplex
molecular
detect
microb
ibi
platform
compar
method
depend
indirect
detect
fluoresc
radioact
report
tag
measur
directli
intrins
physic
properti
molecul
li
et
al
benson
et
al
ecker
et
al
raymond
et
al
use
demonstr
broad
bacteri
surveil
ecker
et
al
identif
viru
famili
includ
coronavirus
sampath
et
al
inf
sampath
et
al
deyd
et
al
jeng
et
al
tang
et
al
adenovirus
blyn
et
al
alphavirus
eshoo
et
al
orthopoxvirus
hofstadl
et
al
enterovirus
piao
et
al
studi
ibi
assay
also
call
use
identifi
multipl
respiratori
virus
nasopharyng
aspir
npa
diagnost
perform
characterist
assay
compar
convent
virolog
procedur
evalu
use
clinic
specimen
npa
specimen
sent
routin
clinic
virolog
laboratori
children
hospit
fudan
univers
identif
respiratori
virus
total
npa
collect
children
year
old
hospit
lower
respiratori
infect
lrti
novemb
octob
lrti
patient
diagnos
basi
criteria
includ
histori
fever
cough
fast
respiratori
rate
age
chest
ronchi
crepit
auscult
npa
sampl
maintain
clinic
virolog
laboratori
standard
virolog
procedur
complet
part
standard
laboratori
protocol
specimen
involv
collect
normal
cours
patient
care
studi
approv
ethic
committe
children
hospit
fudan
univers
direct
immunofluoresc
assay
dfa
diagnost
hybrid
athen
oh
use
screen
respiratori
syncyti
viru
adenoviru
influenza
viru
parainfluenza
viru
human
metapneumoviru
npa
accord
standard
protocol
clinic
virolog
laboratori
total
nucleic
acid
includ
dna
rna
extract
npa
qiaamp
minelut
viru
spin
kit
qiagen
hilden
germani
accord
manufactur
instruct
respiratori
viru
detect
assay
perform
abbott
respiratori
kit
abbott
carlsbad
ca
accord
manufactur
instruct
respiratori
viru
assay
design
use
primer
pair
distribut
well
identifi
respiratori
viral
speci
includ
adenoviru
coronaviru
hmpv
inf
b
c
piv
mump
viru
newcastl
diseas
viru
rsv
et
al
plate
capac
test
six
patient
sampl
briefli
aliquot
dna
rna
ad
well
assay
plate
seal
pcr
amplif
initi
cycl
condit
min
min
min
min
follow
eight
cycl
sec
sec
sec
anneal
temperatur
increas
success
cycl
continu
addit
cycl
sec
sec
sec
end
final
extens
min
follow
hold
subsequ
plate
store
base
composit
analysi
conduct
ms
platform
abbott
use
perform
autom
desalt
signal
acquisit
spectral
analysi
data
report
analyz
pcr
product
previous
describ
chen
et
al
forman
et
al
unambigu
base
composit
deriv
exact
mass
measur
complementari
oligonucleotid
inform
pathogen
acquir
screen
pathogen
databas
discord
dfa
result
resolv
plu
sequenc
cdna
synthesi
perform
use
primescript
kit
rt
kit
takara
dalian
china
accord
manufactur
instruct
brief
total
nucleic
acid
mix
mm
dntp
six
random
primer
incub
min
cool
rt
reaction
conduct
ad
u
rnase
inhibitor
u
primescript
rtase
reaction
mixtur
incub
min
heat
sec
cdna
either
use
immedi
pcr
store
nest
pcr
perform
specif
primer
detect
inf
rsv
hmpv
piv
adenovirus
previous
describ
allard
et
al
coira
et
al
peiri
et
al
first
round
pcr
cdna
amplifi
contain
mm
dntp
pcr
primer
u
taq
dna
polymeras
invitrogen
carlsbad
ca
thermal
cycl
program
follow
min
cycl
sec
sec
min
min
second
round
pcr
first
pcr
product
amplifi
pcr
primer
use
reaction
mixtur
pcr
cycl
condit
pcr
product
analyz
electrophoresi
wv
agaros
gel
stain
ethidium
bromid
dna
fragment
purifi
agaros
gel
use
qiaquick
gel
extract
kit
qiagen
hilden
germani
nucleotid
sequenc
pcr
product
determin
use
bigdy
sequenc
kit
dna
sequenc
appli
biosystem
foster
citi
ca
sequenc
analysi
pcr
product
strain
analyz
seqscann
appli
biosystem
genet
ident
determin
compar
sequenc
standard
strain
genbank
sensit
specif
calcul
use
dfa
result
refer
assay
npa
sampl
test
respiratori
virus
identifi
sampl
assay
found
posit
dfa
overal
agreement
accuraci
dfa
compar
dfa
result
sensit
specif
respect
tabl
compar
dfa
success
verifi
pathogen
includ
rsv
adenovirus
inf
inf
b
hmpv
tabl
ii
addit
detect
singl
virus
clinic
sampl
also
detect
multipl
viral
infect
primarili
dfa
presenc
multipl
pathogen
verifi
subset
nine
clinic
sampl
use
nine
seven
involv
two
virus
two
involv
three
virus
rsv
found
common
viral
follow
adenoviru
tabl
iii
detail
data
obtain
directli
dfa
rsv
strain
type
six
type
b
eight
adenovirus
belong
type
type
type
group
b
four
inf
strain
identifi
pandem
strain
among
origin
specimen
disagr
dfa
result
eleven
confirm
sequenc
eight
multipl
viru
infect
one
sampl
identifi
inf
confirm
convent
pcr
sequenc
analysi
tabl
iii
best
knowledg
studi
first
describ
perform
characterist
novel
platform
use
clinic
specimen
china
assay
use
principl
measur
mass
pcr
amplicon
base
nucleotid
base
composit
ie
number
g
c
nucleotid
dna
molecul
compar
convent
antigen
detect
dfa
show
capac
also
simultan
detect
type
multipl
clinic
relev
respiratori
pathogen
nasopharyng
aspir
patient
lower
respiratori
tract
infect
sensit
specif
found
respect
consist
clinic
trial
data
chen
et
al
demonstr
sever
advantag
regular
dfa
detect
respiratori
virus
first
time
first
result
sampl
prepar
detect
hr
hr
rna
extract
hr
hr
process
estim
throughput
sampl
automat
nucleic
acid
extract
use
one
technician
work
hr
repres
pcr
reaction
howev
dfa
may
requir
least
two
person
complet
number
sampl
within
one
work
day
second
virus
detect
use
especi
inf
rsv
virus
major
viral
agent
caus
lower
respiratori
tract
infect
preval
may
underestim
low
sensit
dfa
sloot
et
al
third
nine
viral
sampl
verifi
wherea
two
detect
dfa
dual
viral
infect
predomin
three
differ
virus
observ
two
sampl
write
clinic
import
multipl
viral
infect
remain
uncertain
et
al
find
indic
provid
inform
dfa
viral
patient
addit
data
help
clarifi
associ
simultan
presenc
one
viral
pathogen
epidemiolog
clinic
featur
differ
singl
infect
especi
respect
diseas
type
sever
fourth
detail
pathogen
character
especi
type
subtyp
inform
rsv
adenoviru
inf
obtain
directli
rapidli
use
detail
inform
obtain
use
dfa
convent
pcr
key
featur
new
technolog
use
ms
quickli
accur
detect
amplicon
weigh
suffici
mass
accuraci
determin
nucleotid
base
composit
associ
sequenc
inform
identifi
genotyp
viru
sampl
speci
viru
found
dfa
howev
compar
low
detect
sensit
adenoviru
mpv
previous
report
two
studi
chen
et
al
forman
et
al
high
degre
agreement
found
dfa
moreov
fact
coronaviru
detect
dfa
studi
similar
anoth
report
chen
et
al
show
low
detect
rate
conronaviru
indic
specimen
need
collect
evalu
diagnost
characterist
respiratori
kit
conronaviru
unlik
assay
base
antigen
detect
nucleic
acid
amplif
limit
detect
known
microb
suitabl
discoveri
pathogen
evalu
emerg
pathogen
base
composit
compar
databas
calcul
base
composit
sequenc
known
organ
determin
ident
microorgan
present
howev
match
found
measur
base
composit
databas
nearest
neighbor
organ
identifi
thu
provid
inform
pathogen
sampl
without
anticip
pathogen
might
present
caliendo
uniqu
technolog
help
rapid
identif
pathogen
regard
emerg
reemerg
infecti
diseas
outbreak
regard
practic
use
new
platform
clinic
diagnosi
limit
need
address
although
test
highli
inform
capac
complet
within
hr
design
use
clinic
laboratori
high
cost
instrument
kit
limit
use
research
studi
respiratori
viru
kit
use
studi
design
detect
rhinovirus
bocavirus
signific
viral
agent
respiratori
tract
infect
modifi
respiratori
viru
surveil
kit
develop
includ
emerg
vital
viral
agent
futur
conclus
new
assay
report
detect
respiratori
virus
clinic
specimen
china
accord
methodolog
assess
assay
sensit
specif
promis
method
detect
subtyp
common
respiratori
virus
caus
respiratori
tract
infect
also
allow
rapid
identif
mix
pathogen
